Your search for ganciclovir returned 21 results

Dr. Reddy’s Laboratories announced the launch of Valganciclovir Tablets, the generic version of Valcyte.

Endo announced the launch of Valganciclovir Tablets, the first generic version of Roche’s Valcyte to be available in the U.S.

Endo announced that Qualitest, its subsidiary, has received final approval from the Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Valganciclovir Tablets, the generic version of Roche’s Valcyte.

Cytomegalovirus may contribute to anemia in patients with chronic kidney disease.

This CME/CEU activity is designed to give clinicians a better understanding of the pharmacology, indications, contraindications, benefits/risk and clinical trials data of a broad spectrum of new agents and those that have been granted a new indication.

A list of contraindications and drug interactions for HIV medications.

The FDA has notified healthcare professionals of new pediatric dosing recommendations for Valcyte (valganciclovir hydrochloride, from Roche) tablets and oral solution.

The FDA has approved a longer duration of therapy with Valcyte (valganciclovir, from Genentech) in adult renal transplant patients at high risk for cytomegalovirus (CMV) disease.

Sirion Therapeutics has announced that Zirgan (ganciclovir ophthalmic gel) is now available for the treatment of acute herpetic keratitis (dendritic ulcers).

The FDA has approved Zirgan (ganciclovir ophthalmic gel, from Sirion Therapeutics) for the treatment of acute herpetic keratitis (dendritic ulcers).